Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| TechTarget Inc | 3,040,676 | reported | 18 Dec 2008 | tx 18−10,229 |
| ACCELERON PHARMA INC | 2,621,738 | reported | 02 Jun 2014 | tx 15+3,121,164−3,725,333 |
| Ruthigen, Inc. | 351,448 | reported | 15 Jun 2015 | tx 19+5,217,568 |
| ALIMERA SCIENCES INC | 87,754 | reported | 27 Apr 2010 | tx 2+378,028 |
| Lyra Therapeutics, Inc. | 0 |
| reported |
| 05 May 2020 |
| tx 10+322,920−11,135,414 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 May 2020 | CONVERSION | Lyra Therapeutics, Inc. | 5,940 | — | |
| 05 May 2020 | CONVERSION | Lyra Therapeutics, Inc. | 316,980 | — | |
| 05 May 2020 | CONVERSION | Lyra Therapeutics, Inc. | 60,642 | — | deriv |
| 05 May 2020 | CONVERSION | Lyra Therapeutics, Inc. | 3,481,517 | — | deriv |
| 05 May 2020 | CONVERSION | Lyra Therapeutics, Inc. | 65,267 | — | deriv |
| 05 May 2020 | CONVERSION | Lyra Therapeutics, Inc. | 827,483 | — | deriv |
| 05 May 2020 | CONVERSION | Lyra Therapeutics, Inc. | 15,513 | — | deriv |
| 05 May 2020 | CONVERSION | Lyra Therapeutics, Inc. | 63,490 | — | deriv |
| 05 May 2020 | CONVERSION | Lyra Therapeutics, Inc. | 3,386,690 | — | deriv |
| 05 May 2020 | CONVERSION | Lyra Therapeutics, Inc. | 3,234,812 | — | deriv |
| 15 Jun 2015 | GRANT_AWARD | Ruthigen, Inc. | 51,330 | — | |
| 15 Jun 2015 | PURCHASE | Ruthigen, Inc. | 714 | 6.88 USD | |
| 15 Jun 2015 | GRANT_AWARD | Ruthigen, Inc. | 22,099 | — | |
| 15 Jun 2015 | PURCHASE | Ruthigen, Inc. | 601 | 6.88 USD | |
| 15 Jun 2015 | GRANT_AWARD | Ruthigen, Inc. | 2,626,762 | — | |
| 15 Jun 2015 | PURCHASE | Ruthigen, Inc. | 71,438 | 6.88 USD | first after silence |
| 15 Jun 2015 | GRANT_AWARD | Ruthigen, Inc. | 18,110 | — | |
| 15 Jun 2015 | PURCHASE | Ruthigen, Inc. | 1,392 | 6.88 USD | |
| 15 Jun 2015 | GRANT_AWARD | Ruthigen, Inc. | 26,172 | — | |
| 15 Jun 2015 | PURCHASE | Ruthigen, Inc. | 489 | 6.88 USD | |
| 15 Jun 2015 | PURCHASE | Ruthigen, Inc. | 32,059 | 6.88 USD | |
| 15 Jun 2015 | GRANT_AWARD | Ruthigen, Inc. | 1,179,066 | — | |
| 15 Jun 2015 | GRANT_AWARD | Ruthigen, Inc. | 7,832 | — | deriv |
| 15 Jun 2015 | GRANT_AWARD | Ruthigen, Inc. | 6,589 | — | deriv |
| 15 Jun 2015 | GRANT_AWARD | Ruthigen, Inc. | 17,710 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 15 Jun 2015.